Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Integrating ePReBMs From Phoenix in Respiratory Diseases

A legfontosabb adatok

Ki végzi
University of Alberta
Hol
Kanada1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Leállítva
Résztvevők
7 fő vett részt
Kezdés
2023. okt. 11.
Befejezés
2024. máj. 6.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Health Gauge AI-Based Wearable Device - Model: Phoenix
A regiszteradat frissítve
2024. október 29.
Miért állt le
Resource Issues

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 14 feltétel megnézéseKevesebb

Ki vehet részt

  • Male or female volunteers, at least 18 years of age at the time of screening visit
  • Fluent in English and able to follow the instructions to use the Health Gauge AI-based Wearable Device
  • Willing and cognitively able to sign informed consent
  • Interstitial lung disease, chronic obstructive pulmonary disease, pulmonary hypertension, or a healthy control

Ki nem vehet részt

  • Subjects with electronic implants of any kind (e.g. pacemaker)
  • An active medical conditions for which they are on chronic treatment with drugs
  • History of active (clinically significant) skin disorders
  • History of allergic response to plastic materials
  • Pregnancy
  • Broken, damaged or irritated skin or rashes near the sensor application sites
  • Subjects who are physically or cognitively unable to normally perform activities of daily living, assessed at the discretion of the investigator
  • Shortness of breath (any sort)
  • Chronic cough
  • Fatigue or difficulty sleeping

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Participants with respiratory disease experience often a worsening of their condition, with increasing symptoms such as cough and shortness of breath. This worsening, often called exacerbation or flare up, impacts on the life of the participants, since they become limited in their daily activities.

A teljes eredeti leírásKevesebb

Healthcare is still based today on limited times for clinical appointments to perform investigations and to meet with specialists/clinicians. Very often, these evaluations do not reflect the way the disease is limiting the patient's life.

Wearable devices offer the opportunity to collect data on physical activities and important clinical parameters (such as how the patient is active or just staying in bed during the day), on a daily basis.

The HG Phoenix AI- based Smart Watch produced by Health Gauge, an Albertan company based in Edmonton, has the potential to measure heart rate, heart rate variability, blood pressure, pulse wave velocity, respiratory rate, temperature, arterial saturation, sleep pattern (deep, light sleep, awake time), duration and time, daily physical activities (site count and distance) and calories burnt in a simple and non-invasive fashion. Ideally, these parameters could be monitored and recorded 24 hours per 7 days per week.

This study aims to demonstrate that this device can be used for a long time at home and it is comfortable to use for the participants, that it is not dangerous and, possibly, that it can help to identify exacerbations before the currently available investigations.

A vizsgálat csoportja

  • Device: Health Gauge AI-Based Wearable Device - Model: PhoenixA vizsgált kezelés

    Kezelés: Health Gauge AI-Based Wearable Device - Model: Phoenix

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From the Health Gauge Phoenix Smart Watch in Respiratory Diseases
A regiszteradat frissítve
2024. október 29.